Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 25, 2025 17:10 ET | Source: Bragar Eagel & Squire

SOLENO INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm

Scorpion Capital report alleged Soleno’s Vykat XR was overpriced, unsafe for kids; shares fell $5.73, or 7.4%, closing at $71.63 on Aug 15, 2025.
September 18, 2025 17:40 ET | Source: Bragar Eagel & Squire

SOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm

Scorpion Capital alleged Soleno’s sole product Vykat XR is overpriced and unsafe for kids. Shares dropped 7.4%, closing at $71.63 on Aug. 15, 2025.
September 08, 2025 17:07 ET | Source: Bragar Eagel & Squire

SOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm

On Aug 15, 2025, a Scorpion report called Soleno’s drug overpriced and unsafe; shares fell 7.4% to $71.63.
September 04, 2025 08:14 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Is Investigating Fortinet, Roblox, Soleno, and Simulations Plus and Encourages Investors to Contact the Firm

NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fortinet, Inc....
August 26, 2025 16:15 ET | Source: Bragar Eagel & Squire

SOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm

On August 15, 2025, Scorpion Capital alleged Soleno's Vykat XR is overpriced and unsafe for kids, causing shares to drop 7.41% to $71.63 that day.